BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7606281)

  • 1. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease.
    Van Gool D; De Strooper B; Van Leuven F; Dom R
    Dementia; 1995; 6(2):63-8. PubMed ID: 7606281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.
    Van Gool D; De Strooper B; Van Leuven F; Triau E; Dom R
    Neurobiol Aging; 1993; 14(3):233-7. PubMed ID: 7686641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.
    Van Gool D; David G; Lammens M; Baro F; Dom R
    Dementia; 1993; 4(6):308-14. PubMed ID: 8136893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study.
    Gearing M; Wilson RW; Unger ER; Shelton ER; Chan HW; Masters CL; Beyreuther K; Mirra SS
    J Neuropathol Exp Neurol; 1993 Jan; 52(1):22-30. PubMed ID: 7678853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
    Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
    J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
    Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
    J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of amyloid precursor fragment in Alzheimer plaques.
    Cole GM; Masliah E; Shelton ER; Chan HW; Terry RD; Saitoh T
    Neurobiol Aging; 1991; 12(2):85-91. PubMed ID: 1711161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease.
    Lippa CF; Ozawa K; Mann DM; Ishii K; Smith TW; Arawaka S; Mori H
    Arch Neurol; 1999 Sep; 56(9):1111-8. PubMed ID: 10488812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome.
    Crino PB; Martin JA; Hill WD; Greenberg B; Lee VM; Trojanowski JQ
    Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):655-61. PubMed ID: 7639477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease.
    Ohgami T; Kitamoto T; Weidmann A; Beyreuther K; Tateishi J
    Am J Pathol; 1991 Dec; 139(6):1245-50. PubMed ID: 1684265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques.
    Joachim C; Games D; Morris J; Ward P; Frenkel D; Selkoe D
    Am J Pathol; 1991 Feb; 138(2):373-84. PubMed ID: 1704190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Amyloid protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease. An autopsy-controlled study.
    Heinonen O; Soininen H; Syrjänen S; Neittaanmäki H; Paljärvi L; Kosunen O; Syrjänen K; Riekkinen P
    Arch Neurol; 1994 Aug; 51(8):799-804. PubMed ID: 8042928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid precursor-like protein 1 accumulates in neuritic plaques in Alzheimer's disease.
    Bayer TA; Paliga K; Weggen S; Wiestler OD; Beyreuther K; Multhaup G
    Acta Neuropathol; 1997 Dec; 94(6):519-24. PubMed ID: 9444352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
    Mrak RE; Sheng JG; Griffin WS
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
    Griffin WS; Sheng JG; Roberts GW; Mrak RE
    J Neuropathol Exp Neurol; 1995 Mar; 54(2):276-81. PubMed ID: 7876895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appearance of localized immunoreactivity for the alpha 4 integrin subunit and for fibronectin in brains from Alzheimer's, Lewy body dementia patients and aged controls.
    Van Gool D; Carmeliet G; Triau E; Cassiman JJ; Dom R
    Neurosci Lett; 1994 Mar; 170(1):71-3. PubMed ID: 8041517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.